TRPM4 is expressed in many organs, including the heart, kidney, and brain (Reading and Brayden, 2007; Abriel et al., 2012; Simard et al., 2013; Flannery et al., 2015; Mehta et al., 2015), and is upregulated in specific cancer cells, rendering it a promising therapeutic target (Berg et al., 2016; Gao and Liao, 2019; Sagredo et al., 2019). This evidence concerns the gene TRPM4 and cancer.